Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants
Clinical trial NCT02141204 · COMPLETED
Trial details
- NCT number
- NCT02141204
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-20
- Primary completion
- 2019-12-28
- Enrollment
- 451
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.